Chapel Hill, NC, United States of America

Laura A Maile

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Laura A Maile

Introduction

Laura A Maile is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 9 patents to her name, her work has the potential to impact various medical treatments and therapies.

Latest Patents

Among her latest patents, Laura has developed monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I. This invention provides αVβ3 integrin cysteine loop domain agonists and antagonists, including peptide agonists and antagonists, along with methods of using these innovations. Another notable patent focuses on monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1). This invention includes an antibody or antigen-binding fragment that binds αβ integrin, with methods of use in the treatment of diseases and disorders.

Career Highlights

Laura A Maile is affiliated with the University of North Carolina at Chapel Hill, where she continues her research and development efforts. Her work has garnered attention in the scientific community, contributing to advancements in therapeutic applications.

Collaborations

Some of her notable coworkers include David Clemmons and Michael Naso, who have collaborated with her on various research projects.

Conclusion

Laura A Maile's innovative work in the field of monoclonal antibodies showcases her dedication to advancing medical science. Her contributions are paving the way for new treatments and therapies that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…